Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Xenotransplantation Oversight Increases: CDC Links To FDA Database

This article was originally published in The Pink Sheet Daily

Executive Summary

CDC will soon outline how to collect, label and ship samples to a new cryopreserved specimen archive, which will be connected to the National Xenotransplantation Database maintained by FDA.

You may also be interested in...



AIDS Vaccine R&D Incentives Could Be Modeled On BioShield, Group Suggests

Creating incentives for the private sector to enter into HIV/AIDS vaccine research and development efforts is one suggestion from the International AIDS Vaccine Initiative in a new report released at the 15th International AIDS Conference in Bangkok.

NCI/FDA Task Force Will Serve As Resource During Approval Process

NCI-funded investigators who reach an impasse in the regulatory process can utilize the "leadership group" of the FDA/NCI Interagency Oncology Task Force. The task force is converting its work into FDA guidance documents.

HHS Research Misconduct Proposed Rule: Adjudication, Burden Of Proof Issues Concern Stakeholders

Proposal to move from use of a three-judge panel to a single administrative law judge to try misconduct cases may be troublesome if complex scientific, technical or medical issues are involved, Federation of American Societies for Experimental Biology and other groups say.

Topics

UsernamePublicRestriction

Register

LL1134044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel